close 73% jaeinvestorite kontodest jääb selle teenusepakkuja juures hinnavahelepingutega kauplemisel kahjumisse. Investeerimisega kaasnevad riskid ja need ei ole sobilikud kõigile investoritele. CFD-d on keerukad instrumendid, millega kaasneb võimenduse tõttu suur risk kaotada raha kiiresti. 73% jaeinvestorite kontodest jääb selle teenusepakkuja juures CFD-dega kauplemisel kahjumisse. Palume teil kaaluda, kas CFD-de toimimine on teile arusaadav ja kas te olete valmis võtma riski, mis suure tõenäosusega on kahjumlik.
Change languageEesti
Ülevaade

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

A

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

A

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

A

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

A

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

A

133.89

-1.33%↓

Kodu・Aktsiate loetelu・Nektar Therapeutics
Search

Nektar Therapeutics

Suletud

35.82 -6.48

Osta

Hinna uuendus 28. jaan 2026, 20:59 UTC

OstaMüü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

35.7

Max

38.16

Põhinäitajad

By Trading Economics

Sissetulek

6.1M

-36M

Müük

615K

12M

Aktsiakasum

-1.87

Kasumimarginaal

-301.289

Töötajad

61

EBITDA

6.9M

-29M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+172.71% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

11. märts 2026

Turustatistika

By TradingEconomics

Turukapital

-383M

756M

Eelmine avamishind

42.3

Eelmine sulgemishind

35.82

Tehniline skoor

By Trading Central

Kindlus

Strong Bearish Evidence

0.5949 / 0.7406 Toetus ja vastupanu

Nektar Therapeutics Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

27. jaan 2026, 23:07 UTC

Tulu

Texas Instruments Says Data Centers, Industrial Recovery Driving Growth into 1Q -- Update

DJ

Loe

27. jaan 2026, 21:27 UTC

Tulu

Texas Instruments 4Q Sales Rise, Profit Falls

DJ

Loe

27. jaan 2026, 23:55 UTC

Market Talk

Yen Weakens Slightly on Possible Technical Correction -- Market Talk

DJ

Loe

27. jaan 2026, 23:47 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

DJ

Loe

27. jaan 2026, 23:47 UTC

Market Talk

Nikkei May Decline Amid Caution Over Earnings -- Market Talk

DJ

Loe

27. jaan 2026, 23:39 UTC

Market Talk

Gold Falls on Likely Technical Correction, Possible Profit-Taking -- Market Talk

DJ

Loe

27. jaan 2026, 23:20 UTC

Tulu

SK Innovation: Asset-Impairment Losses Weighed on Earnings

DJ

Loe

27. jaan 2026, 23:20 UTC

Tulu

SK Innovation: Industry Downturn, Narrower Profit Margins Weighed on Earnings

DJ

Loe

27. jaan 2026, 23:19 UTC

Tulu

SK Innovation Posts Net Loss for Second Consecutive Year

DJ

Loe

27. jaan 2026, 23:19 UTC

Tulu

SK Innovation 2025 Loss KRW5.406T Vs. Loss KRW2.372T >096770.SE

DJ

Loe

27. jaan 2026, 23:18 UTC

Tulu

SK Innovation 2025 Oper Pft KRW448.07B Vs. Pft KRW356.07B >096770.SE

DJ

Loe

27. jaan 2026, 23:18 UTC

Tulu

SK Innovation 2025 Rev KRW80.296T Vs. KRW74.243T >096770.SE

DJ

Loe

27. jaan 2026, 23:11 UTC

Market Talk

Global Equities Roundup: Market Talk

DJ

Loe

27. jaan 2026, 23:11 UTC

Market Talk

Alkane Resources Bull Positive on Outlook in Red-Hot Gold Market -- Market Talk

DJ

Loe

27. jaan 2026, 23:07 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Freightways's Australian M&A Adds Ballast to Bull's View -- Market Talk

DJ

Loe

27. jaan 2026, 22:17 UTC

Market Talk

U.S. Dollar Slips Following Trump Comments -- Market Talk

DJ

Loe

27. jaan 2026, 22:06 UTC

Tulu

Boeing's Stepped-Up Plane Deliveries Lift Sales -- Update

DJ

Loe

27. jaan 2026, 21:51 UTC

Tulu

Texas Instruments Stock Jumps on Strong Outlook -- Barrons.com

DJ

Loe

27. jaan 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

DJ

Loe

27. jaan 2026, 21:43 UTC

Tulu

RTX Stock Jumps After Earnings. It Has 'Great Momentum,' Says CEO. -- Barrons.com

DJ

Loe

27. jaan 2026, 21:41 UTC

Tulu

GM Lost Billions on EVs, Still Beat Wall Street's Expectations -- 5th Update

DJ

Loe

27. jaan 2026, 21:38 UTC

Tulu

These Stocks Are Today's Movers: UnitedHealth, Humana, Micron, Corning, CoreWeave, UPS, GM, and More -- Barrons.com

DJ

Loe

27. jaan 2026, 21:32 UTC

Tulu

Ampol: Modest Profit From F&I International in 2025

DJ

Loe

27. jaan 2026, 21:32 UTC

Tulu

Ampol: F&I Australia Ebit Up by High Single Digit Percent in 2025

DJ

Loe

27. jaan 2026, 21:31 UTC

Tulu

Ampol: New Zealand Ebit in 2025 In Line With Prior Year

DJ

Loe

27. jaan 2026, 21:31 UTC

Tulu

Ampol: Australia Convenience Retail Ebit Up Mid-Single Digit Percent in 2025

DJ

Loe

27. jaan 2026, 21:30 UTC

Tulu

Ampol 4Q Lytton Refinery Production 1.56 Billion Liters

DJ

Loe

27. jaan 2026, 21:29 UTC

Tulu

Ampol FY Unaudited Replacement-Cost Ebitda A$1.44 Billion

DJ

Loe

27. jaan 2026, 21:29 UTC

Tulu

Ampol FY Unaudited Replacement-Cost Operating Profit A$945 Million

DJ

Loe

27. jaan 2026, 21:28 UTC

Tulu

Ampol 4Q Lytton Refiner Margin US$15.14/Bbl

DJ

Loe

Võrdlus sarnastega

Hinnamuutus

Nektar Therapeutics Prognoos

Hinnasiht

By TipRanks

172.71% tõus

12 kuu keskmine prognoos

Keskmine 103.71 USD  172.71%

Kõrge 135 USD

Madal 30 USD

Põhineb 8 Wall Streeti analüütiku instrumendi Nektar Therapeutics 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

8 ratings

6

Osta

1

Hoia

1

Müü

Põhineb 8 analüütiku instrumendi Nektar Therapeutics aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

0.5949 / 0.7406Toetus ja vastupanu

Lühikene perspektiiv

Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Keskpikk perspektiiv

Strong Bearish Evidence

All events are bearish.

Pikk perspektiiv

Bearish Evidence

All events are bearish.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Muud aktsiad sektorist

JNJ

Johnson and Johnson

227.84

↑ +1.49%

ISRG

Intuitive Surgical Inc

522.43

↓-0.51%

ABT

Abbott Laboratories

105.93

↓-2.09%

MDT

Medtronic PLC

100.66

↓-0.05%

A

Agilent Technologies Inc

133.89

↓-1.33%
help-icon Live chat